## DOC: Healthpeak Properties, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -3.7% below STRENGTH zone (3.0-6.0%); PEG 4.08 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($15.92)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Evaluating Diversified Healthcare Trust (DHC) After Its Latest Investor Presentation and Operational Updates**
- Source: Simply Wall Street | 20251210T100923 | Neutral | Relevance: 58%
-  Diversified Healthcare Trust (DHC) recently updated investors on strong operational improvements, including 8% year-over-year SHOP NOI growth and better medical office leasing spreads. This has fueled significant share price gains, with a 114.98% year-to-date return and a 585.76% three-year total shareholder return. While analysts see DHC as undervalued with a fair value of $5.25, Simply Wall St's DCF model suggests the stock may be trading above its intrinsic value at $4.18, warranting caution despite recent positive momentum.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Wells Fargo | $19 | $18 | +6% |
| 2025-11-12 | Baird | $20 | $21 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Wells Fargo | main | Equal-Weight |
| 2025-11-12 | Baird | main | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (-1.9%)
- Blackrock Inc.: 10.5% (-1.7%)
- JPMORGAN CHASE & CO: 8.1% (+182.0%)
- State Street Corpora: 7.1% (+1.8%)
- Principal Financial : 3.9% (-3.2%)

### Key Risks

1. Valuation risk: PEG 4.1x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 8.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.08 signals overvaluation risk, limited margin of safety. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.6B |
| Beta | 1.09 |
| 52W Range | $16.44 - $21.44 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.08 |
| Forward P/E | 66.7 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -6.0% to -3.7% (+2.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.7pp (needs >3.0% for momentum thesis). Below SMA200 (0.92x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.73% (CS: 7) | Weak |
| RSI_14 | 34.6 | Neutral |
| MACD Histogram | -0.12 | Bearish |
| vs SMA20 | 0.955x | Below |
| vs SMA50 | 0.928x | Below |
| vs SMA200 | 0.918x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $16.68
- **Stop Loss:** $15.92 (4.6% risk)
- **Target:** $17.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1815
- **Position Value:** $30,274.20
- **Portfolio %:** 30.27%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-05 (Est: $0.06)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.06 | $-0.18 | -403.2% |
| 2025Q2 | $0.06 | $0.06 | +12.2% |
| 2025Q1 | $0.04 | $0.06 | +40.7% |
| 2024Q4 | $0.05 | $0.05 | -4.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*